Dr. Gaurav Kharya – Leading Pediatric BMT & Hemato-Oncologist Pediatric Hematology, Oncology, Immunology & BMT

Doctor Overview

• Full Name & Designation: Dr. Gaurav Kharya – Senior Consultant, Pediatric Hematology & Clinical Lead, Centre for BMT
• Specialization(s): Pediatric Hemato-Oncology, Bone Marrow Transplantation (BMT), Immunology
• Years of Experience: Over 15 years in pediatric hematology and oncology
• Current Hospital/Institution Affiliation: Indraprastha Apollo Hospitals, New Delhi, India

Qualifications & Credentials

• Medical Degrees:
  • MBBS – Netaji Subhash Chandra Bose Medical College, Jabalpur, India
  • DCH (Diploma in Child Health) – Baba Raghav Das Medical College, Gorakhpur, India
  • DNB (Pediatrics) – Sir Ganga Ram Hospital, New Delhi, India
• Fellowships & Special Training:
  • Fellowship in Pediatric Hematology & Bone Marrow Transplant – St. Mary’s Hospital, Imperial College London, UK
  • Fellowship in Pediatric Hematology-Oncology & BMT – The Great North Children’s Hospital, Newcastle Upon Tyne, UK
  • Fellowship in Pediatric Hematology-Oncology & BMT – Sir Ganga Ram Hospital, New Delhi, India
• Certifications & Accreditations:
  • Fellowship of Indian Academy of Pediatrics (Pediatric Hematology Oncology)

Areas of Expertise

1. Major Conditions Treated:
   • Benign and malignant pediatric blood disorders
   • Pediatric solid tumors (e.g., lymphomas, neuroblastomas, renal tumors)
   • Pediatric immune deficiencies and metabolic disorders
2. Sub-specialties:
   • Bone Marrow Transplantation (BMT)
   • Pediatric Hemato-Oncology
   • Pediatric Immunology
3. Advanced Procedures Performed:
   • Over 1,000 bone marrow transplants, including more than 170 for Sickle Cell Disease (SCD) patients
   • Haploidentical BMT for patients without a full donor match
   • In-vitro TCR alpha-beta CD19 depletion in haploidentical BMT

Professional Experience of Dr Gaurav Kharya

1. Current & Past Hospital Affiliations:
   • Senior Consultant, Pediatric Hematology & Clinical Lead, Centre for BMT – Indraprastha Apollo Hospitals, New Delhi
   • Head, Pediatric Hematology Oncology Immunology & Bone Marrow Transplant – Artemis Hospitals
   • Consultant, Pediatric Hemato-Oncology & Bone Marrow Transplant – BLK Super Speciality Hospital
   • Fellow, Pediatric Hematology & BMT – St. Mary’s Hospital, Imperial College NHS Trust, London, UK
   • Fellow, Pediatric Hemato-Oncology Immunology & BMT – The Great North Children’s Hospital, Newcastle Upon Tyne, UK
2. Academic & Research Roles:
   • Clinical Lead, Centre for Bone Marrow Transplant & Cellular Therapy
   • Running fellowship programs in Bone Marrow Transplant & Cellular Therapy with emphasis on academic and research

• Key Achievements & Contributions:
  • Performed the first haploidentical BMT for Sickle Cell Disease in India
  • Successfully conducted in-vitro TCR alpha-beta CD19 depletion in a 4-month-old baby with severe combined immunodeficiency

Awards & Recognitions

• Recognized for performing the largest number of transplants for Sickle Cell Disease in India
• Developed innovative protocols for various transplants

Research & Publications

• Published Papers:
  • Sanjeev Kumar Sharma, Nitin Gupta, Dharma Choudhary, Vipin Khandelwal, Mayank Dhamija, Gaurav Kharya, Anil Handoo, Arpita Arora, and Rasika Setia: “Cost of Hematopoietic BMT in India.” Mediterr J Hematol Infect Dis 2014, 6(1): e2014046, DOI: 10.4084/MJHID.2014.046
• Book Chapters:
  • Dhiren Gupta and Gaurav Kharya: “Arterial blood gas vs venous blood gas: which one and when?” in Pediatric Emergency Medicine edited by Suresh Gupta, published by Indian Journal of Pediatrics
• Conference Abstracts:
  • A. Prakash, G. Kharya, A. Sachdeva, D. K. Kahlon, M. Kalra, N. Radhakrishnan, V. Dinand, S. P. Yadav: “Is it possible to treat pediatric acute myeloid leukemia in a developing country?” ISH 2010 Jerusalem

Patient Success Stories & Testimonials

• “Dr. Kharya’s expertise in pediatric bone marrow transplantation gave our child a new lease on life.” – Mr Sarkar

  Share Your Concerns

  -- Please select your country --IndiaAfghanistanAland IslandsAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBritish Virgin IslandsBruneiBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCape VerdeCaribbean NetherlandsCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos (Keeling) IslandsColombiaComorosCongo (Brazzaville)Congo (Kinshasa)Cook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzech RepublicDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and McDonald IslandsHondurasHong Kong S.A.R., ChinaHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyIvory CoastJamaicaJapanJerseyJordanKazakhstanKosovoKenyaKiribatiKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacao S.A.R., ChinaMacedoniaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNetherlands AntillesNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorthern Mariana IslandsNorth KoreaNorwayOmanPakistanPalauPalestinian TerritoryPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarReunionRomaniaRussiaRwandaSaint BarthélemySaint HelenaSaint Kitts and NevisSaint LuciaSaint Martin (French part)Saint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth KoreaSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwazilandSwedenSwitzerlandSyriaTaiwanTajikistanTanzaniaThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTurks and Caicos IslandsTuvaluU.S. Virgin IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUnited States Minor Outlying IslandsUruguayUzbekistanVanuatuVaticanVenezuelaVietnamWallis and FutunaWestern SaharaYemenZambiaZimbabwe

• “We are grateful for Dr. Kharya’s compassionate care and dedication throughout our child’s treatment.” – Ms Anita

• “His innovative approach to BMT has been a game-changer for many children suffering from blood disorders.” – Dr Vichitra

• “Dr. Kharya’s commitment to his patients is evident in the successful outcomes we have witnessed.” – Dr Awadh

Outreach, Humanitarian, and Social Impact Work

• Sickle Cell Disease Awareness and Outreach:
  • Dr. Kharya has been at the forefront of awareness campaigns for Sickle Cell Disease (SCD), especially in tribal and under-resourced regions of India where the disease burden is high.
  • He has collaborated with public health bodies to screen and counsel families in high-risk communities, helping them understand the curative potential of Bone Marrow Transplantation.
• Training and Capacity Building:
  • Conducts workshops and training programs for doctors and nurses across India to build expertise in pediatric hematology and BMT.
  • He actively mentors young pediatricians and oncologists in the evolving field of cellular therapy and immunotherapy.
• Charity Transplants and Support Initiatives:
  • Through partnerships with NGOs and philanthropic bodies, Dr. Kharya has facilitated subsidized or free BMTs for economically challenged children.
  • Advocates for universal donor registries and government-aided support schemes for rare blood disorders.

Media Presence & Public Education

• Media Features:
  • Featured in leading national dailies like The Times of India, Hindustan Times, and The Hindu for his pioneering work in haploidentical BMT and immune deficiency treatment in children.
  • Interviews on NDTV, CNN-News18, and Doordarshan discussing advancements in pediatric hematology.
• Public Awareness Videos & Webinars:
  • Regularly participates in public webinars, health talks, and YouTube sessions to educate parents about early detection of blood cancers and immune disorders in children.
  • Hosts Q&A sessions during international awareness days like World Sickle Cell Day, Childhood Cancer Day, and World Marrow Donor Day.
• Social Media Engagement:
  • Active on platforms like LinkedIn and Twitter/X, where he shares research updates, success stories, and myth-busting posts related to bone marrow donation and pediatric cancer care.

Vision & Future Goals

• Establishing a World-Class Pediatric Cell Therapy Institute:
  • Dr. Gaurav Kharya envisions building a center of excellence dedicated solely to pediatric cellular therapies, gene editing, and regenerative medicine within India.
• Global Collaboration:
  • Plans to expand partnerships with international BMT and immunotherapy networks, ensuring Indian patients benefit from cutting-edge protocols and clinical trials.
• National Registry & Policy Advocacy:
  • Advocating for a national sickle cell and thalassemia donor registry and policy support for newborn screening programs, enabling early intervention in hematological conditions.
• Patient-Centric Research:
  • Focus on outcomes-based research in pediatric oncology and BMT, integrating real-world data, quality of life assessments, and long-term survivorship care models.

Research Grants and Trials

• Principal Investigator (PI) on multiple national and international clinical trials exploring novel conditioning regimens for haploidentical BMT, cellular immunotherapies, and gene-modified T cells in pediatric hematologic malignancies.
• Has received funding support from reputed organizations such as:
  • Indian Council of Medical Research (ICMR)
  • Department of Biotechnology (DBT), Government of India
  • European Society for Blood and Marrow Transplantation (EBMT)
• His research in chimerism analysis, GVHD prophylaxis, and T-cell depletion has contributed to evolving clinical protocols and improved patient outcomes.
• Frequently collaborates on multi-center trials involving next-generation sequencing (NGS) for early detection of immunodeficiencies.

Community Engagement and Health Policy Involvement

• Actively involved with NITI Aayog, National Health Mission, and state health departments to shape pediatric oncology policies in India.
• Consultant for Ayushman Bharat schemes to help facilitate inclusion of advanced cellular therapies under government-sponsored healthcare packages.
• Engaged in advocacy for rare disease legislation in India, with focus on making gene therapy and BMT accessible and affordable.
• Regular participant in community events, health camps, and educational outreach programs in both urban and rural India.

Personal Philosophy and Inspirational Journey

• Dr. Gaurav Kharya’s journey from a small-town medical graduate to a globally recognized pediatric BMT expert is rooted in dedication, compassion, and perseverance.
• Believes in a “child-first” approach — combining cutting-edge science with humanistic care to ensure every child, regardless of background, gets a chance at life.
• A mentor and motivator to the next generation of pediatric hematologists, he emphasizes evidence-based practice, empathy in medicine, and lifelong learning.
• Passionate about bridging the gap between high-end therapy and grassroots access, he continues to lead by example — healing with science, hope, and heart.

International Patient Assistance

• Language Support: English, Hindi
• Visa & Travel Assistance: Available via Cancer rounds team
• Virtual Consultations: Available upon request for second opinions and pre-treatment planning

Frequently Asked Questions (FAQs)

What are Dr. Kharya’s major achievements?

He has conducted over 1300 successful BMTs, pioneered CAR-T cell therapy, and treated complex conditions like Wiskott-Aldrich Syndrome, Fanconi Anemia, and Thalassemia Major with high survival rates.

Is Dr. Gaurav Kharya involved in research and clinical trials?

Yes. He is the Principal Investigator in several national and international research trials related to cell therapy, gene-modified T cells, conditioning regimens, and immune reconstitution, supported by agencies like ICMR and DBT.

How does he contribute to pediatric healthcare access in India?

Dr. Kharya works closely with NITI Aayog, state governments, and policy-making bodies to integrate high-end therapies like BMT and gene therapy into public healthcare schemes like Ayushman Bharat.

Has Dr. Kharya received any awards or recognition?

Yes. He has been honored by organizations like the Indian Academy of Pediatrics, Indian Society for Blood and Marrow Transplantation, and international medical societies for his clinical excellence and research contributions.

Is he involved in teaching or mentoring?

Absolutely. Dr. Kharya is a mentor to young pediatricians and hemato-oncologists across India. He regularly speaks at national and international forums, chairs academic panels, and publishes in leading medical journals.

How can patients consult or refer to Dr. Kharya?

Patients can book appointments or referrals through Cancer rounds team. Virtual consultations, international patient programs, and multidisciplinary team reviews are also available for complex pediatric cases.